Top-News
  • Depot
  • Watchlist
  • Glocke
  • Handeln

    • Elite Pharmaceuticals News

    0,1279 $ -1,62% -0,0021 $
    In : 0,1202 € | 22.04.24 15:40:11 Nasdaq OTC Other aktualisieren | Orderbuch | Mehr Kurse »
    WKN: 634826
    ISIN: US28659T2006
    US-Symbol: ELTP
    Typ: Aktie

    Elite Pharmaceuticals News

    09.02.22 - ACCESSWIRE
    Elite Pharmaceuticals, Inc. to Host Conference Call to Provide Corporate Update and Discuss Third Quarter 2022 Financial Results on February 15, 2022
    Financials for Third Quarter Fiscal Year 2022 Ended December 31, 2021 will be released February 14, 2022
    16.11.20 - ACCESSWIRE
    Elite Pharmaceuticals, Inc. Reports Financial Results For The Second Quarter of Fiscal Year 2021 Ended September 30, 2020 and Provides Conference Call Information
    Conference Call Scheduled for Tuesday, November 17 at 11:30 AM EST
    11.11.20 - ACCESSWIRE
    Elite Pharmaceuticals, Inc. To Host Conference Call To Provide Corporate Update and Discuss Second Quarter of Fiscal Year 2021 Results on November 17, 2020
    Financials for Second Quarter of Fiscal Year 2021 ended September 30, 2020 will be released November 16, 2020
    31.03.20 - ACCESSWIRE
    Elite Pharmaceuticals Announces Commercial Launch of Generic Adderall XR(R) with Marketing Partner Lannett Company
    NORTHVALE, NJ / ACCESSWIRE / March 31, 2020 / Elite Pharmaceuticals, Inc. ("Elite" or the "Company") (OTCQB:ELTP) a specialty pharmaceutical company developing niche ...
    11.06.19 - ACCESSWIRE
    Elite Pharmaceuticals, Inc. to Host Conference Call to Provide Corporate Update and Discuss Year-end Financial Results on June 17, 2019
    Financials for Fiscal Year Ended March 31, 2019 will be released June 14, 2019
    05.05.14 - PR Newswire
    Elite Pharmaceuticals Showing Long Term Promise, Analyst Report by BrokerBank Securities, Inc.
    Elite Pharmaceuticals Showing Long Term Promise, Analyst Report by BrokerBank Securities, Inc. PR Newswire
    10.02.14 - PR Newswire
    Elite Pharmaceuticals Analyst Report offers Insight and Market Data by BrokerBank Securities, Inc.
    Elite Pharmaceuticals Analyst Report offers Insight and Market Data by BrokerBank Securities, Inc. PR Newswire
    05.03.07 - Aktiencheck
    Elite Pharmaceuticals "market outperform" - Boenning & Scattergood
    Rating-​Update: West Conshohocken (aktiencheck.de AG) - Die Analysten von Boenning & Scattergood stufen die Aktie von Elite Pharmaceuticals in einer Ersteinschätzung mit ...

    Newssuche

    Videos

    09:10 Uhr
    Technical Trading: S&P 500 Short Chance
    S&P 500 Short Typ: Turbo Open End WKN: UH45D5 Hebel: 2,11 Laufzeit: OpenEnd Einstieg: Market ... Mehr »